Skip to main content
. 2021 Jul 8;25(15):7181–7189. doi: 10.1111/jcmm.16748

FIGURE 3.

FIGURE 3

LfcinB inhibits invasion of breast cancer cell lines. Graph depicting the fold‐change in the relative number of invasive cells in MDA‐MB‐231 and MDA‐MB‐468 cell lines treated with 100‐300 µg/mL of LfcinB for 12 h as determined by Boyden chamber invasion assay. **The results are significant at P < .01